| 000 | 01751 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516030434.0 | ||
| 264 | 0 | _c20110705 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0017698 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoprich, James B | |
| 245 | 0 | 0 |
_aProgressive neurodegeneration or endogenous compensation in an animal model of Parkinson's disease produced by decreasing doses of alpha-synuclein. _h[electronic resource] |
| 260 |
_bPloS one _cMar 2011 |
||
| 300 |
_ae17698 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAxons _xpathology |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aDependovirus _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine Plasma Membrane Transport Proteins _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForelimb |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aNeostriatum _xmetabolism |
| 650 | 0 | 4 |
_aNerve Degeneration _xpathology |
| 650 | 0 | 4 |
_aParkinson Disease _xpathology |
| 650 | 0 | 4 |
_aProsencephalon _xmetabolism |
| 650 | 0 | 4 | _aProtein Transport |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSubstantia Nigra _xenzymology |
| 650 | 0 | 4 |
_aTransgenes _xgenetics |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 650 | 0 | 4 |
_aalpha-Synuclein _xgenetics |
| 700 | 1 | _aJohnston, Tom H | |
| 700 | 1 | _aHuot, Philippe | |
| 700 | 1 | _aReyes, M Gabriela | |
| 700 | 1 | _aEspinosa, Maria | |
| 700 | 1 | _aBrotchie, Jonathan M | |
| 773 | 0 |
_tPloS one _gvol. 6 _gno. 3 _gp. e17698 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0017698 _zAvailable from publisher's website |
| 999 |
_c20679292 _d20679292 |
||